TY - JOUR
T1 - Diverse pathological lesions of primary aldosteronism and their clinical significance
AU - JRAS Study Group
AU - Nishimoto, Koshiro
AU - Umakoshi, Hironobu
AU - Seki, Tsugio
AU - Yasuda, Masanori
AU - Araki, Ryuichiro
AU - Otsuki, Michio
AU - Katabami, Takuyuki
AU - Shibata, Hirotaka
AU - Ogawa, Yoshihiro
AU - Wada, Norio
AU - Sone, Masakatsu
AU - Okamura, Shintaro
AU - Izawa, Shoichiro
AU - Miyauchi, Shozo
AU - Yoshimoto, Takanobu
AU - Tsuiki, Mika
AU - Naruse, Mitsuhide
AU - Katabami, Takuyuki
AU - Fukuda, Hisashi
AU - Tanaka, Yasushi
AU - Takeda, Yoshiyu
AU - Kurihara, Isao
AU - Itoh, Hiroshi
AU - Umakoshi, Hironobu
AU - Tsuiki, Mika
AU - Ichijo, Takamasa
AU - Wada, Norio
AU - Shibayama, Yui
AU - Yoshimoto, Takanobu
AU - Ogawa, Yoshihiro
AU - Kawashima, Junji
AU - Inagaki, Nobuya
AU - Takahashi, Katsutoshi
AU - Fujita, Megumi
AU - Watanabe, Minemori
AU - Matsuda, Yuichi
AU - Kobayashi, Hiroki
AU - Shibata, Hirotaka
AU - Kamemura, Kohei
AU - Otsuki, Michio
AU - Fujii, Yuichi
AU - Rakugi, Hiromi
AU - Yamamoto, Koichi
AU - Ogo, Atsushi
AU - Okamura, Shintaro
AU - Miyauchi, Shozo
AU - Yanase, Toshihiko
AU - Suzuki, Tomoko
AU - Kawamura, Takashi
AU - Sakamoto, Ryuichi
N1 - Funding Information:
Acknowledgements We thank Dr. Yuichiro Fukasawa at Sapporo City General Hospital, Mr. Shinichi Sakamoto at Tenri Hospital, Drs. Takumi Akashi and Yujiro Nakano at Tokyo Medical and Dental University, Dr. Youichi Ohno at Kyoto University, Dr. Ryuichi Sakamoto at Kyushu University, Dr. Aya Saiki at Osaka University, Dr. Yuichi Yoshida at Oita University, and Drs. Kazuhiko Matsuzawa and Kazuhisa Matsu-moto at Tottori University in the JRAS study group for sample collection as well as Mr. Kouichi Kamada at SIMC for his excellent assistance with histochemical and immunohistochemical staining. We also obtained funding support from grants from the Practical Research Project for Rare/ Intractable Disease (JP17ek0109122 and JP20ek0109352, to MN), grants from the National Center for Global Health and Medicine, Japan (27-1402 and 30–1008, to MN), KAKENHI grants (17K16173 to HU, 18K09205 to KN), the Federation of National Public Service Personnel Mutual Aid Associations joint research project 2016 grant (to KN), and a Health Labor Sciences Research grant (H29-Nanji-Ippan-046 to KN and MN).
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/5/1
Y1 - 2021/5/1
N2 - Primary aldosteronism (PA) is mainly clinically classified as unilateral aldosterone-producing adenoma (APA) or bilateral idiopathic hyperaldosteronism. Immunohistochemistry for aldosterone synthase reveals a diverse PA pathology, including pathological APA and aldosterone-producing cell clusters. The relationship between PA pathology and adrenalectomy outcomes was examined herein. Data from 219 unilaterally adrenalectomized PA cases were analyzed. Pathological analyses revealed diverse putative aldosterone-producing lesions. Postoperative biochemical outcomes in 114 cases (test cohort) were classified as complete success (n = 85), partial success (n = 19), and absent success (n = 10). Outcomes in the large and small PA lesion groups, rather than between PA lesion types, were compared at five threshold values for PA lesion sizes (2–6 mm with 1-mm increments) to streamline the results. The proportion of complete success was significantly higher in the large PA lesion group than in the small PA lesion group at the 5-mm threshold only. The proportion of absent success was significantly higher in the small PA lesion group than in the large PA lesion group at all thresholds. Univariate and multivariate analyses of the test cohort identified serum K as an independent predictive factor for the small PA lesion group, which was confirmed in the 105-case validation cohort. Chi-squared automatic interaction detector analysis revealed that the best threshold of serum K for predicting large PA lesions was 2.82 mEq/L. These results will be beneficial for treating PA in clinical settings because patients with low serum K levels and apparent adrenal masses on CT may be subjected to adrenalectomy even if the adrenal venous sampling test is unavailable.
AB - Primary aldosteronism (PA) is mainly clinically classified as unilateral aldosterone-producing adenoma (APA) or bilateral idiopathic hyperaldosteronism. Immunohistochemistry for aldosterone synthase reveals a diverse PA pathology, including pathological APA and aldosterone-producing cell clusters. The relationship between PA pathology and adrenalectomy outcomes was examined herein. Data from 219 unilaterally adrenalectomized PA cases were analyzed. Pathological analyses revealed diverse putative aldosterone-producing lesions. Postoperative biochemical outcomes in 114 cases (test cohort) were classified as complete success (n = 85), partial success (n = 19), and absent success (n = 10). Outcomes in the large and small PA lesion groups, rather than between PA lesion types, were compared at five threshold values for PA lesion sizes (2–6 mm with 1-mm increments) to streamline the results. The proportion of complete success was significantly higher in the large PA lesion group than in the small PA lesion group at the 5-mm threshold only. The proportion of absent success was significantly higher in the small PA lesion group than in the large PA lesion group at all thresholds. Univariate and multivariate analyses of the test cohort identified serum K as an independent predictive factor for the small PA lesion group, which was confirmed in the 105-case validation cohort. Chi-squared automatic interaction detector analysis revealed that the best threshold of serum K for predicting large PA lesions was 2.82 mEq/L. These results will be beneficial for treating PA in clinical settings because patients with low serum K levels and apparent adrenal masses on CT may be subjected to adrenalectomy even if the adrenal venous sampling test is unavailable.
UR - http://www.scopus.com/inward/record.url?scp=85100136779&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100136779&partnerID=8YFLogxK
U2 - 10.1038/s41440-020-00579-w
DO - 10.1038/s41440-020-00579-w
M3 - Article
C2 - 33437027
AN - SCOPUS:85100136779
SN - 0916-9636
VL - 44
SP - 498
EP - 507
JO - Hypertension Research
JF - Hypertension Research
IS - 5
ER -